跳至主要内容
临床试验/NCT00989729
NCT00989729已完成不适用

Preoperative Methylprednisolone in Endovascular Aortic Repair - a Randomized Double Blind Placebo Controlled Clinical Trial

Louise de la Motte1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2009年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
Systemic inflammatory response syndrome - SIRS

研究概览

简要总结

The purpose of this study is to attenuate the systemic inflammatory response after Endovascular repair of abdominal aortic aneurysms, by administration of a single preoperative dosage of Methylprednisolone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Elective endovascular repair of an asymptomatic abdominal aortic aneurysm.
  • Informed signed consent

排除标准

  • Positive HIV status, positive hepatitis B or C status
  • Immunoinflammatory disease - except topically treated skin disease and respiratory disease.
  • Gastric or duodenal ulcer
  • Systemic fungal infection
  • Immunosuppressive treatment
  • Current treatment for cancer
  • Allergy towards contents of Solu-Medrol
  • Alcohol consumption: Men > 21 drinks and women > 14 drinks weekly
  • Pregnancy
  • Lack of informed signed consent
  • Patients where follow up is planned at other location than Rigshospitalet.

研究组 & 干预措施

Methylprednisolone

Active Comparator

75 patients will receive a single preoperative dosage of Methylprednisolone

干预措施: Methylprednisolone (Drug)

Physiological Saline

Placebo Comparator

75 patients will receive a single preoperative dosage of Physiological Saline

干预措施: Physiological Saline (Drug)

结局指标

主要结局

Systemic inflammatory response syndrome - SIRS

时间窗: Within 5 postoperative days

次要结局

  • Length of postoperative hospital stay(Until discharge)
  • Interleukin 6 plasma level(Within 5 postoperative days)
  • Adverse events related to Methylprednisolone(Within 5 postoperative days)

研究者

发起方
Louise de la Motte
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Louise de la Motte

MD

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验